PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2004 | 1 |
| 2008 | 10 |
| 2009 | 13 |
| 2010 | 21 |
| 2011 | 18 |
| 2012 | 19 |
| 2013 | 30 |
| 2014 | 32 |
| 2015 | 38 |
| 2016 | 31 |
| 2017 | 28 |
| 2018 | 18 |
| 2019 | 31 |
| 2020 | 29 |
| 2021 | 17 |
| 2022 | 21 |
| 2023 | 21 |
| 2024 | 15 |
| 2025 | 7 |
| 2026 | 3 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"J Ocul Pharmacol Ther"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits.
- Seetharaman ATM, Owens CE, Gangaraju R.
- J Ocul Pharmacol Ther. 2024 Oct 2;40(10):617-628. doi: 10.1089/jop.2024.0111.
- PMCID: PMC13689522
Seetharaman ATM, et al.J Ocul Pharmacol Ther. 2024.PMCID: PMC13689522 -
Survey of Dopamine Receptor D2 Antagonists as Retinal Antifibrotics.
- Gao AY, Whaley MG, Saraf N, Bakri SJ, Haak AJ.
- J Ocul Pharmacol Ther. 2024 Aug 29;40(8):536-542. doi: 10.1089/jop.2024.0006.
- PMCID: PMC13690261
Gao AY, et al.J Ocul Pharmacol Ther. 2024.PMCID: PMC13690261 -
Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection.
- Durrani AF, Momenaei B, Soni V, Tennant M, Hsu J, Vander J, Spirn M, Kang EY, Hwang YS, Kaushal G, Garg SJ.
- J Ocul Pharmacol Ther. 2024 Aug 22;40(9):581-587. doi: 10.1089/jop.2024.0071.
- PMCID: PMC13689565
Durrani AF, et al.J Ocul Pharmacol Ther. 2024.PMCID: PMC13689565 -
Extracellular Vesicles Derived from Adipose-Derived Mesenchymal Stem Cells Alleviate Apoptosis and Oxidative Stress of Retinal Pigment Epithelial Cells Through Activation of Nrf2 Signaling Pathway.
- Hwang JS, Song HB, Lee G, Jeong S, Ma DJ.
- J Ocul Pharmacol Ther. 2024 Oct 25;40(10):688-701. doi: 10.1089/jop.2024.0064.
- PMCID: PMC13625567
Hwang JS, et al.J Ocul Pharmacol Ther. 2024.PMCID: PMC13625567 -
Topical Application of a Novel Harderian-Derived Nonpolar Lipid Prolongs Tear Film Breakup Time in Normal Beagle Dogs.
- Lantyer-Araujo NL, Park S, Hisey EA, Thomasy SM, Murphy CJ, Albert DM, O'Neill CA, Gadek TR, Parikh AN, Leonard BC.
- J Ocul Pharmacol Ther. 2026 Feb 28;42(1):38-44. doi: 10.1177/10807683251382004.
- PMCID: PMC13102128
Lantyer-Araujo NL, et al.J Ocul Pharmacol Ther. 2026.PMCID: PMC13102128 -
Rose Bengal-Assisted Photodynamic Antimicrobial Therapy for Keratitis.
- Roy A, Kompella UB.
- J Ocul Pharmacol Ther. 2025 May 29;41(7):356-362. doi: 10.1089/jop.2025.0010.
- PMCID: PMC12570877
Roy A, et al.J Ocul Pharmacol Ther. 2025.PMCID: PMC12570877 -
Biodistribution of Reconstituted High-Density Lipoprotein Nanoparticles for Targeted Delivery to Retinal Ganglion Cells.
- Petty RM, Rangan RS, Curry S, Brooks CD, Sabnis N, Clark AF, Lacko AG, Krishnamoorthy RR.
- J Ocul Pharmacol Ther. 2025 Apr 18;41(5):281-289. doi: 10.1089/jop.2024.0191.
- PMCID: PMC12340498
Petty RM, et al.J Ocul Pharmacol Ther. 2025.PMCID: PMC12340498 -
Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol.
- Reitinger JC, Reed DM, Peres C, Fan S, Gulati V, Kazemi A, Sit AJ, Moroi SE, Toris CB.
- J Ocul Pharmacol Ther. 2025 Apr 14;41(5):251-258. doi: 10.1089/jop.2024.0112.
- PMCID: PMC12340499
Reitinger JC, et al.J Ocul Pharmacol Ther. 2025.PMCID: PMC12340499 -
Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application.
- Kashikar R, Senapati S, Dudhipala N, Basu SK, Mandal N, Majumdar S.
- J Ocul Pharmacol Ther. 2024 Jul 8;40(8):504-512. doi: 10.1089/jop.2024.0055.
- PMCID: PMC13178703
Kashikar R, et al.J Ocul Pharmacol Ther. 2024.PMCID: PMC13178703 -
Human RPE Stem Cell-Derived RPE Preserves Photoreceptors in the Royal College of Surgeons Rat: Method for Quantifying the Area of Photoreceptor Sparing.
- Davis RJ, Blenkinsop TA, Campbell M, Borden SM, Charniga CJ, Lederman PL, Frye AM, Aguilar V, Zhao C, Naimark M, Kiehl TR, Temple S, Stern JH.
- J Ocul Pharmacol Ther. 2016 May 16;32(5):304-9. doi: 10.1089/jop.2015.0162.
- PMCID: PMC13175277
Davis RJ, et al.J Ocul Pharmacol Ther. 2016.PMCID: PMC13175277